Progressive systemic scleroderma (PAA) ist characterized by fibroscler
osis of the skin and numerous visceral organs. The prognosis of the di
sease ist decisively determined by its tendency to spread and by the e
xtent of the functional disturbances caused by the disorder. Depending
on the cutaneous fibrosis pattern, various clinical forms of manifest
ation are distinguished, each taking a prognostically different course
. As the disease progresses protractedly, different patterns of fibros
is become manifest which do not go beyond the hand or elbow region. Ho
wever, if the fibrosclerosis ascends from peripheral to proximal upwar
ds or if it develops at the trunk with a fibro-oedema and a tendency t
o centrifugal spreading, the course is over-shadowed by functional dis
turbances of visceral organs. An additional assessment of the prognosi
s of progressive systemic scleroderma becomes possible by means of ant
inuclear antibodies, especially anticentromeric antibodies or scl-70 a
ntibodies; the prognosis is further assisted by including the genes of
the HLA system in the assessment.